Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.32 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3641821 | 0.87 | TNKS (0.33) | CA1CA2TNKSTNKS2 | |
| SCHEMBL9576708 | 0.78 | CA1 (0.39) | CA1CA2PIK3CDPIK3CAPIK3CB | |
| SCHEMBL21662952 | 0.77 | MAPT (0.32) | TNKSTNKS2 | |
| SCHEMBL21456092 | 0.73 | CA1 (0.38) | CA1CA2PIK3CDPIK3CAPIK3CB | |
| SCHEMBL9562242 | 0.73 | CA1 (0.38) | CA1CA2PIK3CDPIK3CAPIK3CB | |
| SCHEMBL25185349 | 0.73 | CDC14B (0.33) | CA1CA2 | |
| SCHEMBL13294461 | 0.72 | CA1 (0.33) | CA1CA2TNKSTNKS2 | |
| SCHEMBL28614424 | 0.71 | CA2 (0.37) | CA1CA2PIK3CDPIK3CAPIK3CB | |
| SCHEMBL25181506 | 0.70 | CA1 (0.39) | CA1CA2 | |
| SCHEMBL20754299 | 0.69 | AHR (0.37) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230146653-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| US-20200039971-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2020-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200039971-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, CYP1A1 | CA1 3590/4885CA2 3905/4885PIK3CD 4205/4885 |
| US-20230146653-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, AOX1 | CA1 924/4885CA2 1893/4885PIK3CD 4768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.